Wyeth pulls cold remedies for kids

Here's a perfect example of the dose-related confusion that has pediatrics experts calling for action against cold meds for kids: More than a half dozen Wyeth products now on store shelves have dosage cups that lack the mark for a half-teaspoon. That's the proper amount for children 2 to 5. The Robitussin and Dimetapp products won't be on shelves for long, though. Wyeth is recalling them to replace their cups with an updated version.

Just three weeks ago, drug makers recalled cold and cough meds for kids under two. Then, an FDA advisory committee hashed over safety and efficacy of these remedies for kids under six--and finally concluded that they shouldn't be used. The agency is now deciding what comes next.

- take a look at this news release from Wyeth
- read the AP article

Related Articles:
FDA panel: No cold meds for under-6 kids. Report
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report

Suggested Articles

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.

Hengrui's Sun Piaoyang is stepping down as chairman, but he'll retain control of the pharma major he's headed for 30 years—and made a fortune…

Astellas tapped Adaptimmune to develop T-cell therapies. Ireland hit Takeda with an unexpected Shire tax bill. PD-1 med Tyvyt hit its goal in NSCLC.